Annual EBIT
$89.29M$37.92M+73.80%
Summary
- Current Value
- As of today, GDRX annual EBIT is $89.29M, up +73.80% on
- Historical Performance
- GDRX annual EBIT is up +222.30% over the past 3 years, and down -37.05% over the past 5 years
- All-Time High Comparison
- GDRX annual EBIT is currently -37.05% below its historical high of $141.85M set on
- 3-Year Low Comparison
- GDRX annual EBIT is +140.28% above its 3-year low of $37.16M reached on an earlier date
- Sector Comparison
- GDRX annual EBIT is higher than 87.14% of companies in Healthcare sector
EBIT Chart
Add series to chart1/6
Series
SUGGESTED SERIES
Performance
| Metric | Date | Value | 1Y | 3Y | 5Y | 15Y |
|---|---|---|---|---|---|---|
| Annual EBIT | $89.29M | +73.8% | +222.3% | -37.0% | +372.0% | |
| Quarterly EBIT | $26.42M | +29.1% | +797.8% | +144.6% | -7.5% | |
| TTM EBIT | $109.95M | +138.7% | +162.4% | +72.5% | +285.0% | |
| Price | $2.85 | -35.4% | -41.1% | -93.2% | – | |
| PE Ratio | 33.18 | -68.0% | – | – | – | |
| Annual Revenue | $792.32M | +5.6% | +6.3% | +104.1% | +697.3% | |
| Annual EPS | $0.04 | +293.5% | +166.3% | -62.3% | +306.9% | |
| Annual EBITDA | $158.83M | -2.6% | +143.1% | +0.8% | +467.1% | |
| Annual Net Income | $16.39M | +284.8% | +164.9% | -61.4% | +310.8% |
EBIT Highs
| Period | High | Date | Current |
|---|---|---|---|
| 3Y | $89.29M | at high | |
| 5Y | $89.29M | at high | |
| All | $141.85M | -37.0% |
EBIT Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 3Y | $37.16M | N/A | +140.3% |
| 5Y | -$267.39M | N/A | +133.4% |
| All | -$267.39M | +133.4% |
EBIT History
| Year | Value | Change |
|---|---|---|
| $89.29M | +73.8% | |
| $51.38M | +38.2% | |
| $37.16M | +34.1% | |
| $27.70M | +110.4% | |
| -$267.39M | -288.5% |
| Year | Value | Change |
|---|---|---|
| $141.85M | +83.6% | |
| $77.27M | +53.6% | |
| $50.31M | +165.9% | |
| $18.92M | - |
FAQ
What is the current annual EBIT of GDRX?
As of today, GDRX annual EBIT is $89.29M
What is 1-year change in GDRX annual EBIT?
GDRX annual EBIT is up +73.80% year-over-year
What is 3-year change in GDRX annual EBIT?
GDRX annual EBIT is up +222.30% over the past 3 years
How far is GDRX annual EBIT from its all-time high?
GDRX annual EBIT is currently -37.05% below its historical high of $141.85M set on December 31, 2019
How does GDRX annual EBIT rank versus sector peers?
GDRX annual EBIT is higher than 87.14% of companies in Healthcare sector
When is GDRX next annual earnings release?
The next annual earnings release for GDRX is on
Quarterly EBIT
$26.42M$1.29M-4.65%
Summary
- Current Value
- As of today, GDRX quarterly EBIT is $26.42M, down -4.65% on
- Historical Performance
- GDRX quarterly EBIT is up +29.06% year-over-year, and up +797.79% over the past 3 years
- All-Time High Comparison
- GDRX quarterly EBIT is currently -40.13% below its historical high of $44.13M set on
- 3-Year Low Comparison
- GDRX quarterly EBIT is +271.01% above its 3-year low of -$15.45M reached on
- Sector Comparison
- GDRX quarterly EBIT is higher than 86.26% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| Quarterly EBIT | $26.42M | -4.7% | +29.1% | +797.8% | +144.6% | |
| Annual EBIT | $89.29M | – | +73.8% | +222.3% | -37.0% | |
| TTM EBIT | $109.95M | +5.7% | +138.7% | +162.4% | +72.5% | |
| Price | $2.85 | -35.1% | -35.4% | -41.1% | -93.2% | |
| PE Ratio | 33.18 | -35.1% | -68.0% | – | – | |
| Quarterly Revenue | $196.03M | -3.5% | +0.4% | +4.7% | +39.6% | |
| Quarterly EPS | $0.00 | -91.1% | -68.6% | +103.2% | +102.5% | |
| Quarterly EBITDA | $47.85M | +0.9% | +25.9% | +169.6% | +190.6% | |
| Quarterly Net Income | $1.12M | -91.3% | -71.8% | +102.7% | +102.2% |
Quarterly EBIT Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | $29.03M | -9.0% | |
| 3Y | $29.03M | -9.0% | |
| 5Y | $29.03M | -9.0% | |
| All | $44.13M | -40.1% |
Quarterly EBIT Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | $26.42M | at low | |
| 3Y | -$15.45M | +271.0% | |
| 5Y | -$294.84M | N/A | +109.0% |
| All | -$294.84M | +109.0% |
Quarterly EBIT History
FAQ
What is the current quarterly EBIT of GDRX?
As of today, GDRX quarterly EBIT is $26.42M
What is GDRX quarterly EBIT most recent change?
GDRX quarterly EBIT was down -4.65% on September 30, 2025
What is 1-year change in GDRX quarterly EBIT?
GDRX quarterly EBIT is up +29.06% year-over-year
How far is GDRX quarterly EBIT from its all-time high?
GDRX quarterly EBIT is currently -40.13% below its historical high of $44.13M set on March 31, 2020
How does GDRX quarterly EBIT rank versus sector peers?
GDRX quarterly EBIT is higher than 86.26% of companies in Healthcare sector
When is GDRX next earnings release?
The next earnings release for GDRX is on
TTM EBIT
$109.95M$5.95M+5.72%
Summary
- Current Value
- As of today, GDRX TTM EBIT is $109.95M, up +5.72% on
- Historical Performance
- GDRX TTM EBIT is up +138.67% year-over-year, and up +162.41% over the past 3 years
- All-Time High Comparison
- GDRX TTM EBIT is currently -31.90% below its historical high of $161.46M set on
- 3-Year Low Comparison
- GDRX TTM EBIT is +486.37% above its 3-year low of $18.75M reached on
- Sector Comparison
- GDRX TTM EBIT is higher than 86.44% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| TTM EBIT | $109.95M | +5.7% | +138.7% | +162.4% | +72.5% | |
| Annual EBIT | $89.29M | – | +73.8% | +222.3% | -37.0% | |
| Quarterly EBIT | $26.42M | -4.7% | +29.1% | +797.8% | +144.6% | |
| Price | $2.85 | -35.1% | -35.4% | -41.1% | -93.2% | |
| PE Ratio | 33.18 | -35.1% | -68.0% | – | – | |
| TTM Revenue | $800.65M | +0.1% | +1.3% | +0.6% | +56.9% | |
| TTM EPS | $0.09 | -7.5% | +319.1% | +149.0% | +62.4% | |
| TTM EBITDA | $191.12M | +5.4% | +35.4% | +102.4% | +129.8% | |
| TTM Net Income | $31.75M | -8.2% | +295.8% | +144.9% | +59.7% |
TTM EBIT Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | $109.95M | at high | |
| 3Y | $109.95M | at high | |
| 5Y | $109.95M | at high | |
| All | $161.46M | -31.9% |
TTM EBIT Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | $88.31M | N/A | +24.5% |
| 3Y | $18.75M | +486.4% | |
| 5Y | -$353.32M | +131.1% | |
| All | -$353.32M | +131.1% |
TTM EBIT History
FAQ
What is the current TTM EBIT of GDRX?
As of today, GDRX TTM EBIT is $109.95M
What is GDRX TTM EBIT most recent change?
GDRX TTM EBIT was up +5.72% on September 30, 2025
What is 1-year change in GDRX TTM EBIT?
GDRX TTM EBIT is up +138.67% year-over-year
How far is GDRX TTM EBIT from its all-time high?
GDRX TTM EBIT is currently -31.90% below its historical high of $161.46M set on June 30, 2020
How does GDRX TTM EBIT rank versus sector peers?
GDRX TTM EBIT is higher than 86.44% of companies in Healthcare sector
When is GDRX next earnings release?
The next earnings release for GDRX is on
EBIT Formula
EBIT = − −
Data Sources & References
- GDRX Official Website www.goodrx.com
- Most Recent Quarterly Report (10-Q) www.sec.gov/Archives/edgar/data/1809519/000180951925000143/0001809519-25-000143-index.htm
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1809519/000180951925000040/0001809519-25-000040-index.htm
- GDRX Profile on Yahoo Finance finance.yahoo.com/quote/GDRX
- GDRX Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/gdrx